Lord's Mark Industries outlines strategic expansion across global healthcare, advanced diagnostics & oncology; targets ₹1,550 Crore revenue in FY2027
In a strategic shift, Lord's Mark Industries is set to launch an extensive healthcare expansion alongside a business demerger. This initiative will prioritize advancements in diagnostics, oncology, and cutting-edge medical devices, bringing CAR-T cell therapy and specialized oncology hospitals to a wider Indian demographic. The company's international vision includes launching subsidiaries in the UK and Switzerland, aiming to bolster its diagnostic capabilities and strengthen its healthcare service value chain.
RSS News
Economic times
0 thoughts on “Lord's Mark Industries outlines strategic expansion across global healthcare, advanced diagnostics & oncology; targets ₹1,550 Crore revenue in FY2027”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- CBI brings back Singapore scam accused absconding since 2013, arrests him at Delhi airport
- IND W vs BAN W: India vs Bangladesh Women's Asia Cup Semi-Finals Today, Know Team India's Playing XI
- Raghav Chandra's column: What is the use of an infrastructure built in a hurry that is not sustainable?
- Boria Majumdar's column: Pakistan blames itself for its poor condition in cricket
- IND vs AFG T20: Harshit Rana OUT? Will Washington play IN, Bumrah and Sundar or not? Watch Updates
